← Cellectis S.A.
| Annual Trend | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $44.8m |
$42.2m
-5.72%
|
$30.1m
-28.67%
|
$30.8m
+2.18%
|
$82.5m
+167.80%
|
$67.1m
-18.66%
|
$19.2m
-71.42%
|
$17.6m
-8.03%
|
$41.5m
+135.41%
|
$72.9m
+75.76%
|
$56.6m
-22.45%
|
|
| Revenue From Interest | $1.6m | $2.0m | $6.8m | $7.0m | $1.9m | $736k | $1.1m | — | — | — | — | |
| Cost of Goods and Services Sold | $1.5m |
$15.8m
+955.42%
|
$10.0m
-36.43%
|
$11.4m
+13.66%
|
$36.3m
+218.43%
|
$31.4m
-13.55%
|
$1.8m
-94.35%
|
$737k
-58.41%
|
$0
-100.00%
|
$0 | $10.0m | |
| Gross Profit (Calculated) (derived) | $43.3m |
$17.9m
-58.56%
|
$11.4m
-36.43%
|
$3.8m
-66.71%
|
$37.7m
+891.94%
|
$25.9m
-31.16%
|
$17.4m
-32.91%
|
$18k
-99.90%
|
$41.5m
+230483.33%
|
$72.9m
+75.76%
|
— | |
| Research and development | $78.5m | $79.2m | $76.6m | $92.0m | $87.0m | $129.0m | $97.5m | $87.6m | $90.5m | $93.5m | $100.7m | |
| Selling, General and Administrative Expense | $43.4m | $44.8m | $47.2m | $43.0m | $44.2m | $37.9m | $17.5m | $16.8m | $19.1m | $19.8m | $9.9m | |
| Operating Lease Income | $161k | — | — | — | — | — | — | — | — | — | — | |
| Operating expenses: | ||||||||||||
| Other Operating Income Expense | ($99k) | $232k | $31k | ($91k) | ($467k) | $511k | $1.4m | ($1.3m) | $849k | $638k | — | |
| Interest Expense | — | — | $39k | $3k | $43k | $355k | $371k | — | — | — | $8.1m | |
| Interest Expense On Lease Liabilities | — | — | — | $2.6m | $3.6m | $5.0m | $3.4m | $3.1m | $2.6m | $2.2m | $8.1m | |
| Other Income | $11.6m | $8.5m | $8.7m | $7.8m | $8.5m | $9.8m | $6.6m | $8.4m | $7.7m | $6.6m | — | |
| Income Tax Expense Continuing Operations | $0 | $0 | $0 | $0 | $0 | $0 | ($87k) | $371k | $0 | ($423k) | ($351k) | |
| Basic Earnings (Loss) Per Share | ($1.91) | ($2.78) | ($1.93) | ($2.41) | ($1.91) | ($2.55) | ($2.33) | ($1.77) | ($0.41) | ($0.67) | ($0.64) | |
| Diluted Earnings (Loss) Per Share | ($1.91) | ($2.78) | ($1.93) | ($2.41) | ($1.91) | ($2.55) | ($2.33) | ($1.77) | ($0.41) | ($0.67) | ($0.64) | |
| Additional Financial Items | ||||||||||||
| Applicable Tax Rate | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | — | |
| Average Effective Tax Rate | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | ($0) | — | |
| Depreciation Amortisation And Impairment Loss Reversal Of Impairment Loss Recognised In Profit Or Loss | — | — | — | — | — | — | — | $10.1m | $10.7m | ($11.3m) | $1.4m | |
| Depreciation And Amortisation Expense | ($2.2m) | ($3.4m) | $2.4m | $6.9m | $9.8m | $7.6m | — | — | — | — | $1.4m | |
| Depreciation Right of Use Assets | — | — | — | — | — | — | $6.7m | — | — | $7.5m | $1.4m | |
| Employee Benefits Expense | — | ($43.0m) | ($28.5m) | — | — | — | — | — | — | — | — | |
| Expense From Share-Based Payment Transactions With Employees | $58.6m | $48.9m | $34.6m | — | — | — | — | — | — | — | — | |
| Finance Costs | $7.1m | $18.3m | $3.8m | $3.6m | $17.5m | $7.7m | $17.8m | $40.6m | $21.6m | $51.1m | — | |
| Finance Income | $7.1m | $7.3m | $20.6m | $12.0m | $5.5m | $13.2m | $8.9m | $21.5m | $44.4m | $16.1m | — | |
| Other Finance Cost | $2.9m | $556k | $677k | $354k | $29k | $197k | $12.5m | $1.1m | $41k | $0 | — | |
| Profit Loss Attributable To Noncontrolling Interests | — | ($4.3m) | ($9.6m) | ($13.1m) | ($16.4m) | ($10.9m) | ($7.9m) | ($7.4m) | $0 | $0 | — | |
| Profit Loss Attributable To Owners Of Parent | ($67.3m) | ($99.4m) | ($78.7m) | ($102.1m) | ($81.1m) | ($114.2m) | ($106.1m) | ($101.1m) | ($36.8m) | ($67.6m) | — | |
| Profit Loss Before Tax | ($67.3m) | ($103.7m) | ($88.3m) | ($115.2m) | ($97.5m) | ($125.1m) | ($98.6m) | ($116.5m) | ($36.8m) | ($68.0m) | — | |
| Profit Loss From Operating Activities | ($67.3m) | ($92.7m) | ($105.1m) | ($123.6m) | ($85.4m) | ($130.7m) | ($89.7m) | ($97.3m) | ($59.6m) | ($33.1m) | — | |
| Net Foreign Exchange Loss | $4.2m | $17.7m | $3.1m | $671k | $13.9m | $2.1m | $1.5m | $13.4m | $5.8m | — | — |